NGVT - Company ID 0001653477
The table below shows Ingevity Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $258.00M | $333.10M | $365.10M | $247.90M | $333.80M | $390.60M |
| Cost of revenue | $141.60M | $199.20M | $227.20M | $136.00M | $202.20M | $267.40M |
| Gross profit | $116.40M | $133.90M | $137.90M | $111.90M | $131.60M | $123.20M |
| R&D | $6.70M | $7.00M | $7.80M | $7.00M | $6.20M | $7.30M |
Ingevity Corp reported annual revenue of $1.17B for fiscal year 2025. That is down 2.7% from $1.20B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $908.30M (FY 2016) to $1.17B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $40.70M | $44.10M | $44.20M | $41.90M | $37.90M | $41.40M |
| Operating income | - | - | - | - | $110.20M | $101.30M |
| Income tax | $6.80M | $21.40M | $3.80M | $8.50M | $6.50M | -$50.90M |
| Net income | $59.80M | $43.50M | -$146.50M | $20.50M | -$107.20M | -$283.70M |
| EPS (diluted) | $1.66 | $1.18 | -$4.02 | $0.56 | -$2.94 | -$7.81 |